Teplizumab (Tzield): A new drug to delay the onset of type 1 diabetes is approved in the US

Artificial pancreas effective in type 2 diabetes: trial

Funding supports vital diabetes research

New report reveals dramatic jump in diabetes costs

Big data, high tech research provides new diabetes leads

Causes for hospitalisation changing for people with type 2 diabetes